Don’t Let Middlemen Off the Hook in Drug Pricing Debate

President Trump’s recent directive to 17 pharmaceutical manufacturers demanding that U.S. drug prices align with the lowest prices in other developed countries has thrust the issue of prescription drug affordability into the spotlight.